Wescott Financial Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.8M Sell
9,306
-154
-2% -$182K 0.79% 27
2026
Q2
$11.3M Buy
9,460
+54
+0.6% +$55.2K 0.88% 25
2026
Q1
$8.65M Sell
9,406
-51
-0.5% -$51.7K 0.76% 26
2025
Q4
$10.2M Buy
9,457
+99
+1% +$94.7K 0.89% 25
2025
Q3
$7.14M Sell
9,358
-26
-0.3% -$19.3K 0.64% 29
2025
Q2
$7.32M Sell
9,384
-3
-0% -$2.33K 0.7% 26
2025
Q1
$7.75M Buy
9,387
+6
+0.1% +$4.99K 0.8% 25
2024
Q4
$7.24M Buy
9,381
+98
+1% +$81.1K 0.75% 26
2024
Q3
$8.22M Buy
9,283
+9
+0.1% +$8.09K 0.88% 21
2024
Q2
$8.4M Buy
9,274
+744
+9% +$595K 0.98% 20
2024
Q1
$6.64M Buy
8,530
+329
+4% +$234K 0.83% 24
2023
Q4
$4.78M Buy
8,201
+209
+3% +$122K 0.67% 30
2023
Q3
$4.29M Buy
7,992
+75
+0.9% +$38.6K 0.78% 28
2023
Q2
$3.71M Buy
+7,917
New +$3.32M 0.66% 32

Other funds holding LLY

Wescott Financial Advisory Group's LLY Position: Q3 2026 in Review

Wescott Financial Advisory Group reduced its Eli Lilly (LLY) stake by 1.6% in Q3 2026, selling an estimated $182K and leaving 9,306 shares worth $10.8M. The position accounts for 0.79% of the portfolio, ranked #27.

Wescott Financial Advisory Group first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $11.3M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Wescott Financial Advisory Group held 9,306 shares of Eli Lilly worth $10.8M as of Q3 2026.
  • Wescott Financial Advisory Group sold 154 Eli Lilly shares in Q3 2026, an estimated $182K.
  • Eli Lilly made up 0.79% of Wescott Financial Advisory Group's portfolio in Q3 2026, its #27 holding.
  • Wescott Financial Advisory Group first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
  • Wescott Financial Advisory Group's Eli Lilly position peaked at $11.3M in Q2 2026.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Wescott Financial Advisory Group's 13F filing for Q3 2026, filed 9 Nov 2026.